Anzeige des vollständigen DOI-Metadaten-Sets

DIESE DOI-METADATEN WURDEN ZULETZT AKTUALISIERT AM: 2024-01-15 14:44

DOI Daten mit Auflösung

10.3280/mesa2022-124oa16279

Artikel

Cite as

Daten zur Zeitschrift
Fortsetzungsausgabe
Daten Fortsetzungsartikel
Zitierungen des 10.3280/mesa2022-124oa16279

Unstructured Zitierung

Borgonovi E. (2004). Aziendalizzazione e governo clinico. Mecosan, 49: 2-6.


Unstructured Zitierung

Borsoi L., Callea G., Marsilio M., Amatucci F., Tarricone R. (2017). Centralized Procurement of Medical Devices In Italy: A Methodology Towards Standardized Tender Dossier. Value in Health, 20.

https://doi.org/10.1016/j.jval.2017.08.1110


Unstructured Zitierung

Braithwaite J., Travaglia J.F. (2008). An overview of clinical governance policies, practices and initiatives. Australian Health Review, 32(1).

https://doi.org/10.1071/AH080010


Unstructured Zitierung

Del Vecchio M., Lega F., Prenestini A., Sartirana M. (2018). Mappatura e valutazione delle competenze cliniche dei professionisti nelle aziende sanitarie: sistemi e strumenti a confronto. In: Cergas Bocconi (a cura di). Rapporto OASI 2018. Milano: Egea.


Unstructured Zitierung

Institute of Medicine (2001). Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: The National Academies Press.


Unstructured Zitierung

Mercurio R., Adinolfi P. (2005). La clinical governance, possibile soluzione ai fabbisogni di integrazione nelle aziende sanitarie. Mecosan, 53.


Unstructured Zitierung

Noto G., Deales A., Di Stanislao F. (2003). Dai profili di assistenza alla Clinical Governance: l’esperienza della Regione Marche. Mecosan, 47.


Unstructured Zitierung

Tarricone R., Boscolo P.R., Armeni P. (2016). What type of clinical evidence is needed to assess medical devices?. European Respiratory Review.

https://doi.org/10.1183/16000617.0016-2016